FTC suit over PBMs’ insulin pricing is delayed in part by Trump firings The postponement is a ‘gift’ to the industry, says former chair Lina Khan

https://www.statnews.com/pharmalot/2025/04/02/ftc-antitrust-insulin-medicine-pharma-pbm-cvs-unitedhealth-optum-cigna-khan/